Landon A. Burcham Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
grad_student
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Landon Burcham, a graduate student at Arkansas State University, focuses on CRISPR and genetic engineering techniques, with a particular interest in virus-based gene therapy and RNA interference for gene delivery. His research explores the application of CRISPR-Cas9 genome editing in the context of Duchenne muscular dystrophy, addressing delivery challenges associated with this approach. Furthermore, Burcham's work incorporates long-read sequencing to elucidate complex genomic and transcriptomic changes resulting from AAV-CRISPR therapy for Duchenne Muscular Dystrophy. He also conducts research on cytomegalovirus and herpesvirus.
Metrics
- h-index: 1
- Publications: 2
- Citations: 14
Selected Publications
-
Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy (2025)
-
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023)
Collaboration Network
Top Collaborators
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy